DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis

Background. Ovarian cancer is the most fatal gynecological malignancy. Owing to its insidious onset, rapid development, and poor prognosis, ovarian cancer is the fifth most common cause of death in women. Although immunotherapy-related drugs, such as Olaparib, can alleviate ovarian cancer progressio...

Full description

Saved in:
Bibliographic Details
Main Authors: Leilei Xia, Ye Wang, Shengyun Cai, Mingjuan Xu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/6636791
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560059079458816
author Leilei Xia
Ye Wang
Shengyun Cai
Mingjuan Xu
author_facet Leilei Xia
Ye Wang
Shengyun Cai
Mingjuan Xu
author_sort Leilei Xia
collection DOAJ
description Background. Ovarian cancer is the most fatal gynecological malignancy. Owing to its insidious onset, rapid development, and poor prognosis, ovarian cancer is the fifth most common cause of death in women. Although immunotherapy-related drugs, such as Olaparib, can alleviate ovarian cancer progression, there are no remarkable breakthroughs for its effective treatment. It is considered that the transformation of normal cells to cancerous ones involves “recoding” of certain metabolic pathways. Diacylglycerol O-acyltransferase 1 (DGAT1) can synthesize triglycerides by transferring acyl-CoA to diacylglycerol, which plays a key role in lipid synthesis. However, the role of DGAT1 in ovarian cancer is not yet elucidated. Materials and Methods. We analyzed the correlation between DGAT1 and ovarian cancer staging, grading, vascular invasion, and prognosis by collating the information of ovarian cancer specimens from The Cancer Genome Atlas (TCGA) database. Furthermore, the effects of DGAT1 expression on proliferation, migration, invasion, and tumor growth were studied using ovarian cancer cell lines. GSEA was used to analyze the KEGG pathways and biological function enriched because of DGAT1 expression in ovarian cancer. Results. The expression of DGAT1 was elevated in advanced (p=0.0432), poorly differentiated (p=0.0148), and vascular invaded (p=0.0002) ovarian cancer specimens. Prognosis among patients with high expression of DGAT1 was poor. After DGAT1 expression was interfered, proliferation, migration, invasion, colony forming, and tumor growth of ovarian cancer cells were inhibited. In addition, GSEA showed that DGAT1 may be involved in the immune process. Conclusion. DGAT1 expression is associated with the clinical phenotype of ovarian cancer. We suggest that DGAT1 has potential implications in the treatment of ovarian cancer.
format Article
id doaj-art-ba972f247e5d4bc993e32f80152d2431
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-ba972f247e5d4bc993e32f80152d24312025-02-03T01:28:29ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/66367916636791DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor PrognosisLeilei Xia0Ye Wang1Shengyun Cai2Mingjuan Xu3Department of Obstetrics and Gynecology, Changhai Hospital, Navy Medical University, Shanghai, ChinaDepartment of Urology, Chinese People’s Liberation Army(PLA) General Hospital/PLA Medical School, Beijing, ChinaDepartment of Obstetrics and Gynecology, Changhai Hospital, Navy Medical University, Shanghai, ChinaDepartment of Obstetrics and Gynecology, Changhai Hospital, Navy Medical University, Shanghai, ChinaBackground. Ovarian cancer is the most fatal gynecological malignancy. Owing to its insidious onset, rapid development, and poor prognosis, ovarian cancer is the fifth most common cause of death in women. Although immunotherapy-related drugs, such as Olaparib, can alleviate ovarian cancer progression, there are no remarkable breakthroughs for its effective treatment. It is considered that the transformation of normal cells to cancerous ones involves “recoding” of certain metabolic pathways. Diacylglycerol O-acyltransferase 1 (DGAT1) can synthesize triglycerides by transferring acyl-CoA to diacylglycerol, which plays a key role in lipid synthesis. However, the role of DGAT1 in ovarian cancer is not yet elucidated. Materials and Methods. We analyzed the correlation between DGAT1 and ovarian cancer staging, grading, vascular invasion, and prognosis by collating the information of ovarian cancer specimens from The Cancer Genome Atlas (TCGA) database. Furthermore, the effects of DGAT1 expression on proliferation, migration, invasion, and tumor growth were studied using ovarian cancer cell lines. GSEA was used to analyze the KEGG pathways and biological function enriched because of DGAT1 expression in ovarian cancer. Results. The expression of DGAT1 was elevated in advanced (p=0.0432), poorly differentiated (p=0.0148), and vascular invaded (p=0.0002) ovarian cancer specimens. Prognosis among patients with high expression of DGAT1 was poor. After DGAT1 expression was interfered, proliferation, migration, invasion, colony forming, and tumor growth of ovarian cancer cells were inhibited. In addition, GSEA showed that DGAT1 may be involved in the immune process. Conclusion. DGAT1 expression is associated with the clinical phenotype of ovarian cancer. We suggest that DGAT1 has potential implications in the treatment of ovarian cancer.http://dx.doi.org/10.1155/2021/6636791
spellingShingle Leilei Xia
Ye Wang
Shengyun Cai
Mingjuan Xu
DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
Journal of Immunology Research
title DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
title_full DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
title_fullStr DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
title_full_unstemmed DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
title_short DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
title_sort dgat1 expression promotes ovarian cancer progression and is associated with poor prognosis
url http://dx.doi.org/10.1155/2021/6636791
work_keys_str_mv AT leileixia dgat1expressionpromotesovariancancerprogressionandisassociatedwithpoorprognosis
AT yewang dgat1expressionpromotesovariancancerprogressionandisassociatedwithpoorprognosis
AT shengyuncai dgat1expressionpromotesovariancancerprogressionandisassociatedwithpoorprognosis
AT mingjuanxu dgat1expressionpromotesovariancancerprogressionandisassociatedwithpoorprognosis